|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:awards
|
gptkb:National_Medal_of_Technology_and_Innovation_(to_Eli_Lilly_and_Company)
|
|
gptkbp:CEO
|
gptkb:David_A._Ricks
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:division
|
gptkb:Lilly_Bio-Medicines
gptkb:Lilly_Diabetes
gptkb:Lilly_Oncology
gptkb:Lilly_Research_Laboratories
|
|
gptkbp:foundedBy
|
Eli Lilly (person)
|
|
gptkbp:foundedYear
|
1876
|
|
gptkbp:headquartersLocation
|
gptkb:Indianapolis,_Indiana,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Eli Lilly
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:logo
|
Eli Lilly and Company logo.svg
|
|
gptkbp:marketCap
|
over $700 billion (2024)
|
|
gptkbp:memberOf
|
gptkb:S&P_500
gptkb:S&P_100
|
|
gptkbp:netIncome
|
$5.2 billion (2023)
|
|
gptkbp:notableAcquisition
|
gptkb:DICE_Therapeutics
gptkb:ImClone_Systems
gptkb:Loxo_Oncology
gptkb:Point_Biopharma
gptkb:Prevail_Therapeutics
|
|
gptkbp:notableEvent
|
Developed first commercially available polio vaccine
Developed first selective serotonin reuptake inhibitor (Prozac)
Developed COVID-19 antibody therapies
First mass producer of insulin
Spun off Elanco Animal Health in 2018
|
|
gptkbp:notableProduct
|
gptkb:Alimta
gptkb:Cymbalta
gptkb:Emgality
gptkb:Humalog
gptkb:Mounjaro
gptkb:Olumiant
gptkb:Prozac
gptkb:Trulicity
gptkb:Verzenio
gptkb:Zyprexa
|
|
gptkbp:numberOfEmployees
|
approximately 41,000 (2023)
|
|
gptkbp:parentCompany
|
none
|
|
gptkbp:researchInterest
|
gptkb:diabetes
immunology
neuroscience
oncology
|
|
gptkbp:revenue
|
$34.1 billion (2023)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:LLY
|
|
gptkbp:subsidiary
|
Elanco (spun off in 2018)
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.lilly.com/
|
|
gptkbp:bfsParent
|
gptkb:Indianapolis
gptkb:礼来
gptkb:礼来公司
gptkb:University_of_the_Sciences
gptkb:Eli_Lilly_and_Company
gptkb:NOVN
|
|
gptkbp:bfsLayer
|
5
|